A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease

Yvelise Ferro, Roberta Pujia, Elisa Mazza, Lidia Lascala, Oscar Lodari, Samantha Maurotti, Arturo Pujia, Tiziana Montalcini

Open source

DOI
10.1186/s12967-022-03579-1
Published
2022-08-19
Container
Journal of Translational Medicine
Publisher
Springer Science and Business Media LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12967-022-03579-1,
  title = {A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease},
  author = {Yvelise Ferro and Roberta Pujia and Elisa Mazza and Lidia Lascala and Oscar Lodari and Samantha Maurotti and Arturo Pujia and Tiziana Montalcini},
  year = {2022},
  journal = {Journal of Translational Medicine},
  doi = {10.1186/s12967-022-03579-1},
  url = {https://doi.org/10.1186/s12967-022-03579-1}
}

RIS

TY  - JOUR
TI  - A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease
AU  - Yvelise Ferro
AU  - Roberta Pujia
AU  - Elisa Mazza
AU  - Lidia Lascala
AU  - Oscar Lodari
AU  - Samantha Maurotti
AU  - Arturo Pujia
AU  - Tiziana Montalcini
PY  - 2022
JO  - Journal of Translational Medicine
DO  - 10.1186/s12967-022-03579-1
UR  - https://doi.org/10.1186/s12967-022-03579-1
ER  - 

APA

Ferro, Y., Pujia, R., Mazza, E., Lascala, L., Lodari, O., Maurotti, S., Pujia, A., & Montalcini, T. (2022). A new nutraceutical (Livogen Plus®) improves liver steatosis in adults with non-alcoholic fatty liver disease. Journal of Translational Medicine. https://doi.org/10.1186/s12967-022-03579-1

Source records